Posted by Michael Wonder on 09 May 2019
Hope for multiple sclerosis sufferers after green light for drug which can delay wheelchair use by seven years
9 May 2019 - Multiple sclerosis patients have welcomed an NHS decision to fund a “landmark” drug which can delay the need for a wheelchair by seven years.
Health chiefs have announced they will soon make available ocrelizumab, the first effective medicine for people suffering from the early primary progressive form of the disease.
It follows an outcry last September after NICE, which decides which treatments should be routinely paid for by the health service, rejected the drug due to its cost.
